Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuf Baran

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Vaccines|March 30, 2023
Therapeutic Potential of Luteolin on CancerMelisa Çetinkaya, Yusuf Baran
Computers in Biology and Medicine|February 12, 2023
scMAGS: Marker gene selection from scRNA-seq data for spatial transcriptomics studiesYusuf Baran, Berat Doğan
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 27, 2015
Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signalingAysun Adan, Yusuf Baran
Critical Reviews in Oncology/Hematology|January 11, 2014
An update on molecular biology of thyroid cancersOzgur Omur, Yusuf Baran
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 18, 2015
The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networksAysun Adan, Yusuf Baran
Journal of Blood Medicine|November 28, 2012
Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemiaYusuf Baran, Guray Saydam
Current Pharmaceutical Biotechnology|August 5, 2022
MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug DevelopmentMelisa Çetinkaya, Yusuf Baran
Hematology (Amsterdam, Netherlands)|June 4, 2009
Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cellsGozde Gucluler, Yusuf Baran
Critical Reviews in Biotechnology|July 3, 2013
Comparative development of knowledge-based bioeconomy in the European Union and TurkeyDidem Celikkanat Ozan, Yusuf Baran
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 14, 2012
Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cellsEsen Yonca Bassoy, Yusuf Baran
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Vaccines|March 30, 2023
Therapeutic Potential of Luteolin on CancerMelisa Çetinkaya, Yusuf Baran
Computers in Biology and Medicine|February 12, 2023
scMAGS: Marker gene selection from scRNA-seq data for spatial transcriptomics studiesYusuf Baran, Berat Doğan
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 27, 2015
Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signalingAysun Adan, Yusuf Baran
Critical Reviews in Oncology/Hematology|January 11, 2014
An update on molecular biology of thyroid cancersOzgur Omur, Yusuf Baran
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 18, 2015
The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networksAysun Adan, Yusuf Baran
Journal of Blood Medicine|November 28, 2012
Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemiaYusuf Baran, Guray Saydam
Current Pharmaceutical Biotechnology|August 5, 2022
MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug DevelopmentMelisa Çetinkaya, Yusuf Baran
Hematology (Amsterdam, Netherlands)|June 4, 2009
Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cellsGozde Gucluler, Yusuf Baran
Critical Reviews in Biotechnology|July 3, 2013
Comparative development of knowledge-based bioeconomy in the European Union and TurkeyDidem Celikkanat Ozan, Yusuf Baran
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 14, 2012
Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cellsEsen Yonca Bassoy, Yusuf Baran
Pageof 9